Skip to main content
Clinical Trials/NCT07630779
NCT07630779RecruitingPhase 3

A Randomized Controlled Trial Evaluating the Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol With or Without Metformin in Non-Diabetic Women With Polycystic Ovary Syndrome

Beni-Suef University1 site in 1 country180 target enrollmentStarted: March 10, 2026Last updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
180
Locations
1

Study Overview

Brief Summary

This study evaluates the efficacy of alpha-lipoic acid combined with myo-inositol, with or without metformin, in improving menstrual regularity and ovulation in non-diabetic women with polycystic ovary syndrome (PCOS). The study also assesses metabolic, hormonal, and clinical outcomes.

Detailed Description

This is a prospective randomized controlled parallel-group clinical trial evaluating the effects of alpha-lipoic acid combined with myo-inositol, with or without metformin, in women with polycystic ovary syndrome (PCOS).

A total of 180 patients will be randomized into three groups:

Myo-inositol with folic acid Myo-inositol + alpha-lipoic acid Myo-inositol + alpha-lipoic acid + metformin

The study duration is 6 months. Outcomes include menstrual regularity, ovulation rate, hormonal parameters, metabolic markers, and clinical signs of hyperandrogenism.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Women aged 21 to 40 years
  • Diagnosed with polycystic ovary syndrome (PCOS) according to Rotterdam criteria
  • Not currently pregnant or lactating
  • No hormonal therapy within the last 3 months
  • Willing and able to provide informed consent

Exclusion Criteria

  • - History of diabetes mellitus, hypertension, or thyroid disorders
  • History of cardiovascular, renal, or hepatic disease
  • Use of hormonal contraceptives or insulin sensitizers within the last 3 months
  • Known hypersensitivity or allergy to study medications (myo-inositol, alpha-lipoic acid, or metformin)
  • Non-Egyptian ethnicity

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Abdelkader

Lecturer Assistant

Beni-Suef University

Study Sites (1)

Loading locations...

Similar Trials